Acura Pharmaceuticals Inc.

(ACUR)

By |

Profile

Acura Pharmaceuticals Inc is a specialty pharmaceutical company based in the United States. It is engaged in the research, development, and commercialization of technologies and products intended to address medication abuse and misuse. The company has developed Aversion and Limitx technologies are intended to address methods of abuse associated with opioid analgesics whereas Impede technology is directed at minimizing the extraction and conversion of pseudoephedrine (PSE), into methamphetamine. Its product line includes OXAYDO which is a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and other pipeline products.

Contact Information

Website: www.acurapharm.com
Email: investors@acurapharm.com
Main Phone: +1 847 705-7709
Address: 616 N. North Court
Address 2: Suite 120
State: IL
City / Town: Palatine
Country: USA
Postal Code: 60067

Issuer Information

Exchange: OTCQB
CEO: Robert B. Jones
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.15 $ -0.069 (-31.51%)
Last Price 0.15 Change $ -0.069 Change % -31.51 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.16 High 0.18 Low 0.13 Prev Close 0.22
Last Trade Volume 11,074 52 Wk Hi 0.87 52 Wk Low 0.10
Market Cap 3.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,033,528.00 EPS (TTM) -0.27 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
J. Bradley Rivet 1,000
Albert W. Brzeczko 1,000
Peter A. Clemens 1,000
Peter A. Clemens 1,000
Bruce F. Wesson 1,000
James F. Emigh 1,000
Bruce F. Wesson 1,000
Bruce F. Wesson 1,000
Bruce F. Wesson 1,000
Bruce F. Wesson 1,000
Last 10 Sell Shares
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
William Skelly 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6 6 6 6
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/16/16 12/16/16 12/16/16 12/16/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1